Governance Classic Home
Amrutanjan Health Care LtdPharmaceuticalsINE098F01031Standalone₹493.65+3.45 (+0.70%)Jun-26
Valuation
Market Cap₹1.43K Cr
TTM PE26.45x
Forward PE26.76x
PEG-3.90
Book Value₹128.06
P/B3.86x
TTM EPS₹18.67
Fwd EPS₹18.45
TTM Revenue₹511.48 Cr
TTM PAT₹53.97 Cr
TTM EBITDA₹73.49 Cr
TTM EBIT₹66.78 Cr
Last Qtr PAT₹4.37 Cr
Last Qtr EBITDA₹6.24 Cr
Last Qtr EBIT₹4.32 Cr
Profitability
ROE14.58%
ROCE20.00%
TTM NPM10.55%
TTM EBITDA %14.37%
Curr OPM4.09%
Last OPM10.48%
Curr NPM—
Last NPM—
Curr EPS₹1.51
Last EPS₹5.60
Balance sheet
Equity₹2.89 Cr
Reserve₹367.34 Cr
Total Debt₹2.22 Cr
D/E0.01x
Interest %0.92%
Curr Interest₹0.04 Cr
Price / range
Close₹493.80
vs 52W High-36.04%
vs 52W Low+3.63%
MA50—
MA200—
Returns
1D+0.57%
1W+0.67%
1M+1.02%
3M-9.38%
6M-4.95%
1Y-34.16%
2Y-38.73%
3Y-21.84%
5Y+27.70%
Diwali-25.98%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr148.173.58%
DIVISLAB9375.00₹2.49L Cr84.6217.55%
TORNTPHARM4840.00₹1.84L Cr78.8025.43%
ZYDUSLIFE1160.00₹1.16L Cr33.2112.96%
CIPLA1394.50₹1.13L Cr36.648.93%
LAURUSLABS1954.00₹1.06L Cr120.9216.46%
AUROPHARMA1734.00₹99.77K Cr38.796.84%
DRREDDY1185.00₹98.91K Cr148.681.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue102.97+9.5%149.77141.04117.7094.05502.55
Other Income3.814.734.124.304.4317.57
Total Income106.78+8.4%154.50145.1612298.47520.13
Interest0.040.050.050.050.050.20
Expenditure-98.69-13.2%-125.88-117.54-102.78-87.18-433.38
PBDT000000
EBITDA6.24-26.2%25.5525.1716.538.4575.69
Depreciation-1.92-1.61-1.62-1.56-1.53-6.32
EBIT4.32-37.6%23.9423.5514.976.9269.37
PBT6.07-46.2%21.0226.3619.2211.2977.89
Tax-1.70-4.82-6.91-5.25-2.98-19.97
Equity2.892.89002.892.89
OPM5.6813.6118.6916.3311.4714.97
Net Profit4.37-47.4%16.1919.4513.968.3157.92
NPM4.0910.4813.7911.868.4411.14
EPS1.51-47.4%5.606.734.832.8720.03

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue502.55+11.2%451.82+7.3%421.23+11.0%379.64-6.5%405.84+21.9%332.84
Other Income17.5717.6816.3514.5415.3811.32
Total Income520.13+10.8%469.50+7.3%437.58+11.0%394.18-6.4%421.23+22.4%344.16
Expenditure-433.38-8.2%-400.36-6.6%-375.63-10.3%-340.53-3.0%-330.65-26.1%-262.26
Interest-0.20-0.22-0.16-0.08-0.49-0.50
PBDT000000
EBITDA75.69+30.0%58.21+12.3%51.82+16.7%44.40-44.1%79.48+6.3%74.75
Depreciation-6.32-6.53-6.06-5.21-3.80-3.67
EBIT69.37+34.2%51.68+12.9%45.76+16.8%39.19-48.2%75.68+6.5%71.08
PBT77.89+12.7%69.13+11.6%61.95+15.5%53.65-40.8%90.58+10.6%81.91
Tax-19.97-18.30-16.97-13.81-23.39-20.71
Equity2.892.890000
OPM (%)14.9714.7314.0014.0022.0024.00
Net Profit57.92+13.9%50.83+13.0%44.97+12.9%39.84-40.7%67.19+9.8%61.19
NPM (%)11.1410.8310.0010.0016.0018.00
EPS (Rs)20.03+13.9%17.58+13.0%15.56+14.0%13.65-40.8%23.05+10.1%20.94
CEPS20.0317.5815.5613.6323.0320.93

Consolidated

16 lines · 1 periods
MetricFY25-26
Revenue502.55
Other Income17.57
Total Income520.13
Interest0.20
Expenditure-433.38
PBDT0
EBITDA75.69
Depreciation-6.32
EBIT69.37
PBT77.89
Tax-19.97
Equity2.89
OPM14.97
Net Profit57.92
NPM11.14
EPS20.03

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue502.55+11.2%451.82
Other Income17.5717.68
Total Income520.13+10.8%469.50
Expenditure-433.38-8.2%-400.36
Interest-0.20-0.22
PBDT00
EBITDA75.69+30.0%58.21
Depreciation-6.32-6.53
EBIT69.37+34.2%51.68
PBT77.89+12.7%69.13
Tax-19.97-18.30
Equity2.892.89
OPM (%)14.9714.73
Net Profit57.92+13.9%50.83
NPM (%)11.1410.83
EPS (Rs)20.03+13.9%17.58
CEPS20.0317.58

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

49
YearTypeAmountEx-Date
2026Final Dividend2.911 Sep 2026
2026Interim Dividend106 Feb 2026
2026Interim Dividend118 Nov 2025
2025Final Dividend2.616 Sep 2025
2025Interim Dividend118 Feb 2025
2025Interim Dividend122 Nov 2024
2025Interim Dividend121 Nov 2024
2024Final Dividend2.613 Sep 2024
2024Interim Dividend120 Feb 2024
2024Interim Dividend123 Nov 2023
2023Final Dividend2.614 Sep 2023
2023Interim Dividend124 Feb 2023
2023Interim Dividend114 Nov 2022
2022Final Dividend2.614 Sep 2022
2022Interim Dividend118 Feb 2022
2022Interim Dividend116 Nov 2021
2021Final Dividend2.615 Sep 2021
2021Interim Dividend0.817 Feb 2021
2021Interim Dividend0.819 Nov 2020
2020Interim Dividend1.5518 Feb 2020
2020Interim Dividend0.5515 Nov 2019
2019Final Dividend1.0517 Sep 2019
2019Interim Dividend0.5520 Feb 2019
2019Interim Dividend0.5512 Nov 2018
2018Final Dividend0.8507 Sep 2018
2018Interim Dividend1.122 Feb 2018
2018Interim Dividend1.116 Nov 2017
2017Final Dividend1.6513 Sep 2017
2017Interim Dividend1.116 Feb 2017
2017Interim Dividend1.117 Nov 2016
2016Interim Dividend2.6518 Mar 2016
2016Interim Dividend1.217 Feb 2016
2015Final Dividend2.410 Sep 2015
2015Interim Dividend1.113 Feb 2015
2014Final Dividend2.217 Sep 2014
2014Interim Dividend117 Feb 2014
2013Final Dividend202 Aug 2013
2013Interim Dividend121 Feb 2013
2012Final Dividend1020 Sep 2012
2012Interim Dividend523 Feb 2012
2011Final Dividend1012 Sep 2011
2011Interim Dividend521 Feb 2011
2010Final Dividend1013 Aug 2010
2010Interim Dividend509 Feb 2010
2009Final Dividend1216 Sep 2009
2009Interim Dividend504 Feb 2009
2008Final Dividend308 Sep 2008
2009Interim Dividend4028 Jul 2008
2008Interim Dividend405 Feb 2008

Bonus

0

No bonus history.

Split

2
YearRatioEx-Date
2018Rs.2/- to Rs.1/-13 Apr 2018
2012Rs.10/- to Rs.2/-25 Oct 2012
Loading company dashboard...
Fetching ratios, charts, and peers